We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
+22.32%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$215B
AUM Growth
+$28.1B
Cap. Flow
+$1.96B
Cap. Flow %
0.91%
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189M
2
HON icon
Honeywell
HON
+$157M
3
AAPL icon
Apple
AAPL
+$124M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$62.1M

Sector Composition

Rank Sector Weight
1 Technology 25.83%
2 Financials 11.43%
3 Communication Services 6.64%
4 Consumer Discretionary 6.57%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPL icon
2351
Amplitude
AMPL
$1.57B
$288K ﹤0.01%
37,624
WOOF icon
2352
Petco
WOOF
$780M
$287K ﹤0.01%
105,515
-135,975
-56% -$377K
ACEL icon
2353
Accel Entertainment
ACEL
$999M
$286K ﹤0.01%
22,711
LBRX
2354
LB Pharmaceuticals
LBRX
$1.51B
$284K ﹤0.01%
8,753
PTRN
2355
Pattern Group Inc
PTRN
$3.67B
$283K ﹤0.01%
11,251
+2,581
+30% +$43.8K
PAR icon
2356
PAR Technology
PAR
$771M
$283K ﹤0.01%
16,257
MCBS icon
2357
MetroCity Bankshares
MCBS
$1.04B
$282K ﹤0.01%
7,850
GERN icon
2358
Geron
GERN
$975M
$281K ﹤0.01%
219,833
INN
2359
Summit Hotel Properties
INN
$638M
$281K ﹤0.01%
40,097
GDOT icon
2360
Green Dot
GDOT
$766M
$281K ﹤0.01%
20,804
ANRO icon
2361
Alto Neuroscience
ANRO
$1.33B
$281K ﹤0.01%
10,649
FIZZ icon
2362
National Beverage
FIZZ
$2.9B
$280K ﹤0.01%
8,986
JELD icon
2363
JELD-WEN Holding
JELD
$164M
$280K ﹤0.01%
186,888
-24,196
-11% -$37.3K
COAG
2364
Hemab Therapeutics
COAG
$2.47B
$280K ﹤0.01%
+7,616
New +$210K
GLSI icon
2365
Greenwich LifeSciences
GLSI
$254M
$278K ﹤0.01%
11,871
+1,536
+15% +$37.4K
DHT icon
2366
DHT Holdings
DHT
$3.01B
$278K ﹤0.01%
16,792
+7,937
+90% +$142K
ASST icon
2367
Strive Inc
ASST
$1.11B
$277K ﹤0.01%
25,395
+4,712
+23% +$69.7K
TDUP icon
2368
ThredUp
TDUP
$381M
$275K ﹤0.01%
40,142
CSTL icon
2369
Castle Biosciences
CSTL
$921M
$274K ﹤0.01%
11,502
TALK icon
2370
Talkspace
TALK
$871M
$274K ﹤0.01%
52,637
ALOY
2371
REalloys Inc
ALOY
$931M
$273K ﹤0.01%
+18,901
New +$215K
NPK icon
2372
National Presto Industries
NPK
$1.03B
$273K ﹤0.01%
2,183
OPK icon
2373
Opko Health
OPK
$985M
$273K ﹤0.01%
181,766
AMBQ
2374
Ambiq Micro
AMBQ
$1.65B
$273K ﹤0.01%
3,087
-44
-1% -$2.61K
DRUG
2375
Bright Minds Biosciences
DRUG
$766M
$272K ﹤0.01%
3,870
+812
+27% +$63.8K

Similar funds

Vanguard Global Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

  • Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
  • Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
  • Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
  • Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
  • Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
  • Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.